Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites - AstraZeneca (NYSE:AZN), Johnson &
AI disclosure
Summary
Eli Lilly plans to invest $4.5 billion in Indiana, expanding its U.S. manufacturing footprint and supporting new weight-loss treatments.